See more : Chofu Seisakusho Co., Ltd. (5946.T) Income Statement Analysis – Financial Results
Complete financial analysis of Aveanna Healthcare Holdings Inc. (AVAH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aveanna Healthcare Holdings Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Ujjivan Financial Services Limited (UJJIVAN.NS) Income Statement Analysis – Financial Results
- CHO Pharma, Inc. (6586.TWO) Income Statement Analysis – Financial Results
- Cathay Financial Holding Co., Ltd. (2882.TW) Income Statement Analysis – Financial Results
- Guangdong High Dream Intellectualized Machinery Co., Ltd. (300720.SZ) Income Statement Analysis – Financial Results
- Taisho Pharmaceutical Holdings Co., Ltd. (4581.T) Income Statement Analysis – Financial Results
Aveanna Healthcare Holdings Inc. (AVAH)
About Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.90B | 1.79B | 1.68B | 1.50B | 1.38B | 1.25B |
| Cost of Revenue | 1.30B | 1.23B | 1.14B | 1.04B | 964.81M | 859.35M |
| Gross Profit | 595.43M | 553.23M | 542.40M | 454.52M | 419.25M | 394.32M |
| Gross Profit Ratio | 31.42% | 30.95% | 32.31% | 30.40% | 30.29% | 31.45% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 443.13M | 483.95M | 427.77M | 354.77M | 341.00M | 321.84M |
| Selling & Marketing | 8.57M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 473.30M | 483.95M | 427.77M | 354.77M | 341.00M | 321.84M |
| Other Expenses | 114.06M | 36.11M | 20.21M | 17.94M | 16.64M | -13.74M |
| Operating Expenses | 587.36M | 520.06M | 447.98M | 372.71M | 357.64M | 339.71M |
| Cost & Expenses | 1.89B | 1.75B | 1.58B | 1.41B | 1.32B | 1.20B |
| Interest Income | 327.00K | 679.00K | 253.00K | 345.00K | 207.00K | 594.00K |
| Interest Expense | 153.25M | 99.94M | 68.93M | 82.98M | 92.30M | 75.54M |
| Depreciation & Amortization | 30.10M | 38.82M | 35.39M | 30.22M | 27.01M | 11.94M |
| EBITDA | 44.35M | -517.28M | -9.26M | 22.13M | 44.28M | 96.11M |
| EBITDA Ratio | 2.34% | 3.64% | 7.83% | 7.50% | 5.19% | 4.26% |
| Operating Income | 8.07M | 26.31M | 95.97M | 81.95M | 38.95M | 39.03M |
| Operating Income Ratio | 0.43% | 1.47% | 5.72% | 5.48% | 2.81% | 3.11% |
| Total Other Income/Expenses | -147.07M | -21.54M | -77.47M | -48.25M | -113.98M | -88.69M |
| Income Before Tax | -139.00M | -663.81M | -113.58M | -51.73M | -75.03M | -49.66M |
| Income Before Tax Ratio | -7.33% | -37.13% | -6.77% | -3.46% | -5.42% | -3.96% |
| Income Tax Expense | -4.47M | -1.78M | 3.47M | 5.32M | 1.49M | -2.51M |
| Net Income | -134.52M | -662.03M | -117.04M | -57.05M | -76.52M | -47.15M |
| Net Income Ratio | -7.10% | -37.03% | -6.97% | -3.82% | -5.53% | -3.76% |
| EPS | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 |
| EPS Diluted | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 |
| Weighted Avg Shares Out | 189.96M | 185.55M | 184.73M | 185.90M | 185.90M | 180.16M |
| Weighted Avg Shares Out (Dil) | 189.96M | 185.55M | 184.73M | 185.90M | 185.90M | 180.16M |
Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain
Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?
Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference
Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Aveanna Stock Rallies 110% in 3 Months: Is It Still Worth Buying?
Are You Looking for a Top Momentum Pick? Why Aveanna Healthcare (AVAH) is a Great Choice
Despite Fast-paced Momentum, Aveanna (AVAH) Is Still a Bargain Stock
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now?
Aveanna Healthcare Holdings Inc. (AVAH) Q2 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports